BriaCell Therapeutics Corp. (BCTX)
4.43
+0.11
(+2.55%)
USD |
NASDAQ |
Apr 07, 16:00
4.45
+0.02
(+0.45%)
After-Hours: 20:00
BriaCell Therapeutics EPS Diluted (Quarterly) : -2.577 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hear AtLast Holdings, Inc. | -0.0006 |
| Pharmagreen Biotech, Inc. | -0.0017 |
| CeCors, Inc. | -- |
| Venus Concept, Inc. | -12.14 |
| Achieve Life Sciences, Inc. | -0.2752 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.297M |
| Total Expenses (Quarterly) | 7.222M |
| Enterprise Value | 1.514M |
| Earnings Yield | -610.2% |
| Normalized Earnings Yield | -622.47 |